http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#Head http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#assertion http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#provenance http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#pubinfo http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#assertion http://purl.obolibrary.org/obo/DOID_409 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_409 http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01039 http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association http://www.w3.org/2000/01/rdf-schema#label "Fenoglide is contraindicated in patients with severe renal dysfunction, including those receiving dialysis [see Clinical Pharmacology (12.3) Fenoglide is contraindicated in patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities [see Warnings and Precautions (5.1) Fenoglide is contraindicated in patients with gallbladder disease [see Warnings and Precautions (5.2) Fenoglide is contraindicated in nursing mothers [see Use in Specific Populations (8.3) Fenoglide is contraindicated in patients who have a known hypersensitivity to fenofibrate, such as severe skin rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis. [see Warnings and Precautions (5.9) Severe renal dysfunction, including patients receiving dialysis ( 4 12.3 Active liver disease ( 4 5.1 Gallbladder disease ( 4 5.2 Nursing mothers ( 4 8.3" http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB01039 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#provenance http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#pubinfo http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#sig http://purl.org/nanopub/x/hasSignature gzpouB/HsT/F/lyzDqXWhW5CLhxMdJPmxEF1OCJv9xXJyMPrF2E1c6a/olTYSsWtFlor8r57KVvu3vltR8+hvF8nALFeR1XdmRVCL2T7F4n4B/aOIWDVLD3LzXs0ZT5eW2yh3OhL+mm6AzO4maw3+8sAC20vVaKjdLVKB4ZEf8U= http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A http://purl.org/dc/terms/created 2021-08-22T17:24:55.921+02:00 http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAbSm0mV_DjuDcEx-sPIiVILXrrkkY385kOyaa7pxYF0A https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY